Tumor agnostic drug delivery with dynamic nanohydrogels
Abstract RNA interference (RNAi) holds unique potential as a clinically viable modality to pharmacologically regulate oncogenes in sequence-specific manner. However, systemic delivery of RNAi to tumors encounters myriad obstructions, and strategies to overcome such barriers have largely consisted of...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Portfolio
2026-01-01
|
| Collection: | Nature Communications |
| Accès en ligne: | https://doi.org/10.1038/s41467-025-66788-4 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|